Abstract
AIM: The goal of this study is to investigate the involvement of inflammatory cytokines produced by tumor-associated macrophages in promoting tumor angiogenesis. METHODS: To study the angiogenic effect of tumor-associated macrophages (TAMs), we overlaid human umbilical vein endothelial cells on top of Matrigel containing MCF-7 breast cancer cells with or without macrophages and investigated the outcome of endothelial cell capillary tube and network formation. We also determined the levels of interleukin (IL)-1β, IL-6, IL-8, IL-b, IL-12p70, tumor necrosis factor-α (TNF-α), and vascular endothelial growth factor (VEGF) in the media of MCF-7 breast cancer cells co-cultivated with or without macrophages. Furthermore, anti-IL-8 receptor antagonizing antibody, IL-6 or TNF-α soluble receptor, and inhibitors against NF-κB, MEK, p38(superscript MAPK), and JNK, respectively, were used to determine which signal transduction pathways are involved in TAMs-induced angiogenic activity. RESULTS: The Matrigel mixed with MCF-7 cells and macrophages was more efficient than 100 ng/ml of VEGF to induce vascular endothelial cell tube and network formation. The expression of IL-6, IL-B and TNF-α were significantly enhanced by cocultivation of MCF-7 cells with macrophages. The promotion of capillary tube and network formation by TAMs was inhibited either with anti-IL-8 receptor antagonizing antibody or with IL-6 or TNF-α soluble receptor, suggesting that IL-8, TNF-α and IL-6 indeed participated in TAMs-induced angiogenesis. In addition, TAMs-induced angiogenic activity could also be attenuated by the presence of inhibitors against NF-κB, ERK, and p38(superscript MAPK) signaling pathways. CONCLUSION: IL-8, TNF-α and IL-6 were involved in TAMs-associated angiogenesis via a NF-κB, ERK, and p38(superscript MAPK)-dependent signaling pathways.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.